tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Bio Rad Laboratories Inc

BIO
Add to Watchlist
325.480USD
-0.980-0.30%
Close 07-31 16:00（ET）Quotes delayed by 15 min
8.63BMarket Cap
53.98P/E TTM

Bio Rad Laboratories Inc

325.480
-0.980-0.30%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BIO Financials

See Bio Rad Laboratories Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Bio Rad Laboratories Inc Earnings Date

Latest Release
Aug 4, 2026
EPS / Forecast
--/1.75
Revenue / Forecast
--/623.99M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
2.58B
0.65%
EPS(YoY)
27.87
142.64%
Analyst Rating
HOLD
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-953.63%-19.55
204.40%26.69
-154.34%-12.70
115.31%11.67
-82.99%2.29
-310.47%-25.57
540.07%23.37
-92.62%-76.26
477.75%13.46
-56.74%12.15
--3.65
---39.59
--2.33
--28.08
---149.41
----
----
----
----
----
Revenue
1.14%592.10M
3.85%693.20M
0.50%653.00M
2.06%651.60M
-4.16%585.40M
-2.01%667.48M
2.79%649.73M
-6.26%638.48M
-9.75%610.82M
-6.72%681.18M
-7.15%632.12M
-1.45%681.11M
-3.32%676.84M
-0.34%730.29M
-8.87%680.80M
-3.47%691.10M
-3.68%700.06M
-7.23%732.77M
15.42%747.05M
33.35%715.93M
Net Profit
-923.59%-527.10M
200.59%720.00M
-152.34%-341.90M
114.68%317.80M
-83.33%64.00M
-304.69%-715.80M
514.71%653.17M
-86.32%-2.17B
456.71%383.92M
-58.04%349.71M
165.27%106.26M
-25.63%-1.16B
102.05%68.96M
153.25%833.49M
-104.14%-162.81M
-201.20%-925.11M
-444.52%-3.37B
-284.79%-1.57B
198.75%3.93B
-5.41%914.11M
Net Margin
-914.27%-89.02%
196.85%103.87%
-152.08%-52.36%
114.38%48.77%
-82.61%10.93%
-308.89%-107.24%
498.05%100.53%
-98.76%-339.16%
516.88%62.85%
-55.02%51.34%
--16.81%
---170.64%
--10.19%
--114.13%
---215.03%
----
----
----
----
----
Gross Margin
-1.51%52.25%
-2.90%49.74%
-4.16%52.50%
-4.86%53.01%
-0.73%53.06%
-4.76%51.22%
3.09%54.78%
3.71%55.71%
-0.27%53.45%
-0.26%53.78%
--53.14%
--53.72%
--53.59%
--53.92%
--56.48%
----
----
----
----
----
Debt to assets ratio
-2.57%12.29%
-11.36%11.37%
9.48%12.40%
-4.97%11.77%
32.59%12.62%
31.57%12.83%
12.39%11.33%
23.77%12.39%
8.51%9.52%
9.90%9.75%
--10.08%
--10.01%
--8.77%
--8.87%
--9.93%
----
----
----
----
----
Income Statement
Revenue
1.14%592.10M
3.85%693.20M
0.50%653.00M
2.06%651.60M
-4.16%585.40M
-2.01%667.48M
2.79%649.73M
-6.26%638.48M
-9.75%610.82M
-6.72%681.18M
-7.15%632.12M
-1.45%681.11M
-3.32%676.84M
-0.34%730.29M
-8.87%680.80M
-3.47%691.10M
-3.68%700.06M
-7.23%732.77M
15.42%747.05M
33.35%715.93M
Operating profit
-40.07%34.10M
6.12%61.90M
-29.34%66.40M
-20.58%79.50M
9.83%56.90M
-40.12%58.33M
1.64%93.97M
-0.22%100.10M
-31.39%51.81M
-22.55%97.42M
-2.32%92.45M
-18.37%100.32M
-48.42%75.51M
9.96%125.78M
-39.64%94.65M
4.96%122.89M
-17.03%146.41M
-38.37%114.39M
44.65%156.80M
115.06%117.08M
Net Profit
-923.59%-527.10M
200.59%720.00M
-152.34%-341.90M
114.68%317.80M
-83.33%64.00M
-304.69%-715.80M
514.71%653.17M
-86.32%-2.17B
456.71%383.92M
-58.04%349.71M
165.27%106.26M
-25.63%-1.16B
102.05%68.96M
153.25%833.49M
-104.14%-162.81M
-201.20%-925.11M
-444.52%-3.37B
-284.79%-1.57B
198.75%3.93B
-5.41%914.11M
Balance Sheet
Current assets
-3.11%2.94B
-4.10%2.91B
-6.99%2.84B
-8.02%2.81B
-0.80%3.04B
-0.59%3.03B
-2.90%3.06B
-2.63%3.06B
-6.60%3.06B
-3.47%3.05B
0.21%3.15B
-3.41%3.14B
-0.79%3.28B
58.65%3.16B
27.32%3.14B
41.96%3.25B
51.86%3.30B
-6.98%1.99B
6.13%2.47B
7.34%2.29B
Total current liabilities
81.01%917.00M
10.52%517.00M
4.89%522.30M
12.72%548.90M
8.68%506.60M
-10.52%467.80M
-10.79%497.94M
-16.33%486.96M
-20.94%466.15M
-8.07%522.80M
-2.19%558.18M
-5.17%581.98M
-9.06%589.62M
-16.48%568.71M
-12.19%570.68M
4.54%613.71M
6.30%648.33M
7.82%680.94M
-34.13%649.92M
-36.66%587.05M
Total assets
2.76%9.79B
12.95%10.58B
-8.55%9.70B
5.43%10.21B
-24.45%9.53B
-23.86%9.36B
-10.86%10.60B
-19.12%9.69B
-7.74%12.61B
-8.91%12.30B
-1.35%11.90B
-5.55%11.98B
-4.91%13.67B
-24.15%13.50B
-39.57%12.06B
-16.11%12.68B
3.16%14.37B
37.21%17.80B
65.99%19.95B
49.72%15.12B
Total liabilities
3.20%2.94B
11.74%3.12B
-5.01%2.96B
6.04%3.09B
-19.99%2.85B
-21.45%2.79B
-10.46%3.12B
-17.60%2.91B
-8.84%3.56B
-8.45%3.56B
-3.47%3.48B
-6.07%3.53B
-6.85%3.90B
-5.54%3.89B
-21.99%3.60B
6.72%3.76B
26.07%4.19B
33.03%4.11B
44.60%4.62B
28.38%3.52B
Total equity
2.57%6.85B
13.46%7.45B
-10.03%6.74B
5.16%7.13B
-26.20%6.68B
-24.85%6.57B
-11.03%7.49B
-19.75%6.78B
-7.30%9.05B
-9.09%8.74B
-0.44%8.42B
-5.33%8.45B
-4.12%9.76B
-29.74%9.62B
-44.86%8.45B
-23.05%8.92B
-4.02%10.18B
38.52%13.69B
73.74%15.33B
57.68%11.59B
Cash Flow Statement
Net operating income
-16.78%108.10M
32.77%164.90M
-9.30%120.90M
19.36%116.50M
86.10%129.90M
53.24%124.20M
36.42%133.30M
-0.48%97.60M
-28.85%69.80M
-10.37%81.05M
785.34%97.72M
84.10%98.07M
94.26%98.10M
-47.08%90.42M
-95.21%11.04M
-65.55%53.27M
-55.55%50.50M
-41.96%170.87M
69.81%230.37M
67.85%154.62M
Net investment
-3313.79%-93.20M
-11.97%-34.20M
22.71%-43.00M
-273.14%-115.40M
106.73%2.90M
-142.31%-30.54M
-485.64%-55.64M
-210.52%-30.93M
38.85%-43.09M
204.16%72.20M
89.26%-9.50M
119.37%27.98M
92.31%-70.47M
87.78%-69.31M
-8.69%-88.42M
-44.08%-144.48M
-1795.71%-916.14M
-849.62%-567.43M
-189.54%-81.35M
-13.21%-100.28M
Net financing
54.96%-44.00M
112.57%3.30M
45.30%-52.50M
-41.12%-136.30M
-465338.10%-97.70M
86.92%-26.25M
-260.88%-95.99M
52.36%-96.59M
-99.51%21.00K
-131.61%-200.62M
-203.21%-26.60M
-67.10%-202.74M
-99.64%4.31M
-1968.80%-86.62M
43.70%-8.77M
-4334.76%-121.33M
2613.98%1.19B
101.10%4.63M
-3649.43%-15.58M
196.17%2.87M

FAQs

What is the total revenue of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its total revenue reached 2.58B, with a year-on-year change of 2.57B.

What are the current assets of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its current assets were 2.91B, with a year-on-year change of -4.10.

What are the total assets of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its total assets of Bio Rad Laboratories Inc were 10.58B, with a year-on-year change of 12.95.

What are the total liabilities of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its total liabilities of Bio Rad Laboratories Inc were 3.12B, with a year-on-year change of 11.74.

What is the total equity of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its total equity of Bio Rad Laboratories Inc was 7.45B, with a year-on-year change of 13.46.

What is the net operating income of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its net operating income of Bio Rad Laboratories Inc was 264.70M, with a year-on-year change of -11.32.

What is the net investment of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its net investment of Bio Rad Laboratories Inc was -189.70M, with a year-on-year change of -18.41.

What is the net financing of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its net financing of Bio Rad Laboratories Inc was -283.20M, with a year-on-year change of -29.43.

What is the Earnings Per Share (EPS) of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 27.87, with a year-on-year change of 142.64.

What is the net income of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its net income was 759.90M, with a year-on-year change of 141.20.

What is the net margin of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its net profit margin was 29.42, with a year-on-year change of 140.94.

What is the gross margin of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its gross margin was 52.01, with a year-on-year change of -3.19.

What is the debt-to-asset ratio of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its debt-to-asset ratio was 11.37, with a year-on-year change of -11.36.

What is the Return on Equity (ROE) of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its Return on Equity (ROE) was 10.84, with a year-on-year change of 144.99.

What is the Return on Assets (ROA) of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its Return on Assets (ROA) was 7.62, with a year-on-year change of 144.76.

What is the operating profit of Bio Rad Laboratories Inc?

According to Bio Rad Laboratories Inc's FY2025 earnings report, its operating profit was 264.70M, with a year-on-year change of -11.32.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy